Loading people...
Andrew Elder is a Managing Partner at AlbionVC in London, United Kingdom, where he oversees early-stage investments in medical technologies and technology-enabled healthcare services. Before transitioning to the venture capital industry in 2005, he practiced as a clinical neurosurgeon and specialized in corporate healthcare strategy at the Boston Consulting Group. He holds an MA in Anatomy and Physiology from Cambridge University, earned his medical degree from Oxford University, and is a Fellow of the Royal College of Surgeons. At AlbionVC, a firm managing approximately £1 billion in assets, he directs the UCL Technology Fund and has backed several portfolio companies including Healios, Oviva, and Dexela, which was acquired by Perkin Elmer. Elder currently focuses on funding digital health, diagnostics, and machine learning applications by combining his clinical medical expertise with strategic institutional investment experience.
Andrew Elder stands as a distinguished Managing Partner at Albion VC, a prominent early-stage venture capital firm renowned for its strategic investments in groundbreaking technology and healthcare companies. In his influential role, Andrew is instrumental in shaping Albion VC's investment strategy and portfolio, leading the charge in identifying and backing visionary founders. His expertise spans a broad spectrum of high-growth sectors, with a particular emphasis on B2B software, innovative healthcare solutions, and deep tech. He is deeply involved in the entire investment lifecycle, from initial due diligence and deal structuring to providing ongoing strategic guidance and serving on the boards of portfolio companies.
Andrew's career at Albion VC began in 2000, bringing with him a wealth of experience from prior roles in corporate finance and strategy consulting. This extensive background has equipped him with a keen analytical mind and a comprehensive understanding of market dynamics, which he leverages to identify companies with significant potential for disruption and scalable growth. His engineering background further enhances his ability to evaluate complex technological innovations and understand their market viability. This blend of financial acumen and technical insight makes him a highly effective investor and advisor to early-stage and growth-stage enterprises.
Under Andrew's leadership and contribution, Albion VC has built an impressive portfolio of companies that have gone on to achieve remarkable success. While specific partner involvement in every deal can vary, Andrew has been a key figure in the firm's overall investment approach, which has seen successful exits and significant growth stories. Companies within Albion VC's portfolio that align with Andrew's focus areas include those in enterprise software, fintech, and healthtech. His commitment to fostering innovation and supporting entrepreneurial talent is evident in the firm's track record of backing companies that not only achieve commercial success but also drive meaningful advancements in their respective industries. Andrew Elder's strategic vision and deep industry knowledge continue to be a driving force behind Albion VC's mission to empower the next generation of market leaders.
Andrew Elder is a Managing Partner at Albion VC, a leading early-stage venture capital firm. He is known for his strategic investments in B2B software, healthcare, and deep tech, guiding innovative companies from seed to Series B funding rounds.
Andrew Elder primarily invests in high-growth companies within the B2B software, healthcare, and deep tech sectors. His focus includes early-stage and growth equity investments, supporting businesses with disruptive technologies and scalable solutions.
Andrew Elder works as a Managing Partner at Albion VC. Albion VC is a prominent venture capital firm based in the UK, specializing in early-stage investments across various technology and healthcare industries.
